Effect of Antenatal Corticosteroids on Respiratory Morbidity in Singletons After Late-Preterm Birth

Department of Obstetrics and Gynecology, Columbia University, New York, New York 10032, USA.
Obstetrics and Gynecology (Impact Factor: 5.18). 03/2012; 119(3):555-9. DOI: 10.1097/AOG.0b013e31824758f6
Source: PubMed


To evaluate whether neonates born to women who previously had received antenatal corticosteroids and then delivered a late-preterm-birth neonate had less respiratory morbidity compared with those not exposed to antenatal corticosteroids.
This is a secondary analysis from a multicenter observational study regarding mode of delivery after previous cesarean delivery. We compared women who received one course of antenatal corticosteroids with unexposed parturients and evaluated various respiratory outcomes among those having a singleton, late-preterm-birth neonate. We controlled for potential confounders including gestational age at delivery, diabetes, mode of delivery, and maternal race.
Five thousand nine hundred twenty-four patients met the inclusion criteria; 550 received steroids and 5,374 did not. In the univariable model, compared with unexposed women, those who received antenatal corticosteroids appeared more likely to have neonates who required ventilatory support (11.5% compared with 8.6%, P=.022), had respiratory distress syndrome (RDS) (17.1% compared with 12.2%, P=.001), developed transient tachypnea of the newborn (12.9% compared with 9.8%, P=.020), or required resuscitation in the delivery room (55.8% compared with 49.7%, P=.007). After controlling for confounding factors, we found no significant differences among the groups regarding all of the above outcomes with an odds ratio for RDS of 0.78 (95% confidence interval, 0.60-1.02) and ventilator support of 0.75 (95% confidence interval, 0.55-1.03).
Exposure to antenatal corticosteroids does not significantly affect respiratory outcomes among those with a subsequent late-preterm birth.

Download full-text


Available from: Cynthia Gyamfi,
  • [Show abstract] [Hide abstract]
    ABSTRACT: It is well recognised that birth before 32 weeks of gestation is associated with substantial neonatal morbidity and mortality and these risks have been extensively reported. The focus of perinatal research for many years has therefore been very preterm and extremely preterm delivery, since the likelihood and severity of adverse neonatal outcomes are highest within this group. In contrast, until recently, more mature preterm infants have been understudied and indeed, almost ignored by researchers.
    Fetal and Maternal Medicine Review 05/2012; 23(02). DOI:10.1017/S0965539512000071
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The objective of this study was to determine whether acute histologic chorioamnionitis is associated with adverse neonatal outcomes in late preterm infants who were born after preterm PROM. The relationship between the presence of acute histologic chorioamnionitis and adverse neonatal outcome was examined in patients with preterm PROM who delivered singleton preterm newborns between 34 weeks and 36 6/7 weeks of gestation. Nonparametric statistics were used for data analysis. The frequency of acute histologic chorioamnionitis was 24% in patients with preterm PROM who delivered preterm newborns between 34 weeks and 36 6/7 weeks of gestation. Newborns born to mothers with histologic chorioamnionitis had significantly higher rates of adverse neonatal outcome (74% vs 51%; p<0.005) than those without histologic chorioamnionitis. This relationship remained significant after adjustment for gestational age at preterm PROM, gestational age at delivery, and exposure to antenatal corticosteroids. The presence of acute histologic chorioamnionitis is associated with adverse neonatal outcome in late preterm infants born to mothers with preterm PROM.
    PLoS ONE 12/2013; 8(12):e79941. DOI:10.1371/journal.pone.0079941 · 3.23 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Preterm birth is a leading cause of perinatal mortality and morbidity and continues to be one of the most common complications plaguing obstetrics and neonatology. Primary prevention of preterm birth remains the ultimate but elusive goal. However, efforts to curtail the impact of preterm birth are of great importance. Use of antenatal corticosteroids (ACSs) in threatened preterm labor has been one of the landmark interventions that have improved the neonatal outcome. Since the start of use of ACS: the acceptance has increased dramatically and now it has become the standard of care in threatened preterm labor. However, there are still many unresolved issues surrounding the usage of ACS. In this article, we attempt to synthesize the current available evidence and its application in our daily clinical scenarios.
    Expert Review of Obstetrics &amp Gynecology 01/2014; 8(6). DOI:10.1586/17474108.2013.842688
Show more